Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Equity Ratio (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Equity Ratio for 5 consecutive years, with 0.71 as the latest value for Q4 2022.

  • Quarterly Equity Ratio fell 12.25% to 0.71 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.71 through Dec 2022, down 12.25% year-over-year, with the annual reading at 0.71 for FY2022, 13.06% down from the prior year.
  • Equity Ratio for Q4 2022 was 0.71 at NovaBridge Biosciences, down from 0.81 in the prior quarter.
  • The five-year high for Equity Ratio was 0.89 in Q4 2020, with the low at 1.17 in Q4 2019.
  • Average Equity Ratio over 5 years is 0.17, with a median of 0.71 recorded in 2022.
  • The sharpest move saw Equity Ratio tumbled 191.3% in 2019, then surged 175.87% in 2020.
  • Over 5 years, Equity Ratio stood at 0.4 in 2018, then plummeted by 191.3% to 1.17 in 2019, then soared by 175.87% to 0.89 in 2020, then decreased by 8.37% to 0.81 in 2021, then decreased by 12.25% to 0.71 in 2022.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.71, 0.81, and 0.89 for Q4 2022, Q4 2021, and Q4 2020 respectively.